Cargando…
Forced Self-Modification Assays as a Strategy to Screen MonoPARP Enzymes
Mono(ADP-ribosylation) (MARylation) and poly(ADP-ribosylation) (PARylation) are posttranslational modifications found on multiple amino acids. There are 12 enzymatically active mono(ADP-ribose) polymerase (monoPARP) enzymes and 4 enzymatically active poly(ADP-ribose) polymerase (polyPARP) enzymes th...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036481/ https://www.ncbi.nlm.nih.gov/pubmed/31855104 http://dx.doi.org/10.1177/2472555219883623 |
_version_ | 1783500226627108864 |
---|---|
author | Wigle, Tim J. Church, W. David Majer, Christina R. Swinger, Kerren K. Aybar, Demet Schenkel, Laurie B. Vasbinder, Melissa M. Brendes, Arne Beck, Claudia Prahm, Martin Wegener, Dennis Chang, Paul Kuntz, Kevin W. |
author_facet | Wigle, Tim J. Church, W. David Majer, Christina R. Swinger, Kerren K. Aybar, Demet Schenkel, Laurie B. Vasbinder, Melissa M. Brendes, Arne Beck, Claudia Prahm, Martin Wegener, Dennis Chang, Paul Kuntz, Kevin W. |
author_sort | Wigle, Tim J. |
collection | PubMed |
description | Mono(ADP-ribosylation) (MARylation) and poly(ADP-ribosylation) (PARylation) are posttranslational modifications found on multiple amino acids. There are 12 enzymatically active mono(ADP-ribose) polymerase (monoPARP) enzymes and 4 enzymatically active poly(ADP-ribose) polymerase (polyPARP) enzymes that use nicotinamide adenine dinucleotide (NAD(+)) as the ADP-ribose donating substrate to generate these modifications. While there are approved drugs and clinical trials ongoing for the enzymes that perform PARylation, MARylation is gaining recognition for its role in immune function, inflammation, and cancer. However, there is a lack of chemical probes to study the function of monoPARPs in cells and in vivo. An important first step to generating chemical probes for monoPARPs is to develop biochemical assays to enable hit finding, and determination of the potency and selectivity of inhibitors. Complicating the development of enzymatic assays is that it is poorly understood how monoPARPs engage their substrates. To overcome this, we have developed a family-wide approach to developing robust high-throughput monoPARP assays where the enzymes are immobilized and forced to self-modify using biotinylated-NAD(+), which is detected using a dissociation-enhanced lanthanide fluorescence immunoassay (DELFIA) readout. Herein we describe the development of assays for 12 monoPARPs and 3 polyPARPs and apply them to understand the potency and selectivity of a focused library of inhibitors across this family. |
format | Online Article Text |
id | pubmed-7036481 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-70364812020-03-10 Forced Self-Modification Assays as a Strategy to Screen MonoPARP Enzymes Wigle, Tim J. Church, W. David Majer, Christina R. Swinger, Kerren K. Aybar, Demet Schenkel, Laurie B. Vasbinder, Melissa M. Brendes, Arne Beck, Claudia Prahm, Martin Wegener, Dennis Chang, Paul Kuntz, Kevin W. SLAS Discov Original Research Mono(ADP-ribosylation) (MARylation) and poly(ADP-ribosylation) (PARylation) are posttranslational modifications found on multiple amino acids. There are 12 enzymatically active mono(ADP-ribose) polymerase (monoPARP) enzymes and 4 enzymatically active poly(ADP-ribose) polymerase (polyPARP) enzymes that use nicotinamide adenine dinucleotide (NAD(+)) as the ADP-ribose donating substrate to generate these modifications. While there are approved drugs and clinical trials ongoing for the enzymes that perform PARylation, MARylation is gaining recognition for its role in immune function, inflammation, and cancer. However, there is a lack of chemical probes to study the function of monoPARPs in cells and in vivo. An important first step to generating chemical probes for monoPARPs is to develop biochemical assays to enable hit finding, and determination of the potency and selectivity of inhibitors. Complicating the development of enzymatic assays is that it is poorly understood how monoPARPs engage their substrates. To overcome this, we have developed a family-wide approach to developing robust high-throughput monoPARP assays where the enzymes are immobilized and forced to self-modify using biotinylated-NAD(+), which is detected using a dissociation-enhanced lanthanide fluorescence immunoassay (DELFIA) readout. Herein we describe the development of assays for 12 monoPARPs and 3 polyPARPs and apply them to understand the potency and selectivity of a focused library of inhibitors across this family. SAGE Publications 2019-12-19 2020-03 /pmc/articles/PMC7036481/ /pubmed/31855104 http://dx.doi.org/10.1177/2472555219883623 Text en © 2019 Society for Laboratory Automation and Screening https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Research Wigle, Tim J. Church, W. David Majer, Christina R. Swinger, Kerren K. Aybar, Demet Schenkel, Laurie B. Vasbinder, Melissa M. Brendes, Arne Beck, Claudia Prahm, Martin Wegener, Dennis Chang, Paul Kuntz, Kevin W. Forced Self-Modification Assays as a Strategy to Screen MonoPARP Enzymes |
title | Forced Self-Modification Assays as a Strategy to Screen MonoPARP
Enzymes |
title_full | Forced Self-Modification Assays as a Strategy to Screen MonoPARP
Enzymes |
title_fullStr | Forced Self-Modification Assays as a Strategy to Screen MonoPARP
Enzymes |
title_full_unstemmed | Forced Self-Modification Assays as a Strategy to Screen MonoPARP
Enzymes |
title_short | Forced Self-Modification Assays as a Strategy to Screen MonoPARP
Enzymes |
title_sort | forced self-modification assays as a strategy to screen monoparp
enzymes |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036481/ https://www.ncbi.nlm.nih.gov/pubmed/31855104 http://dx.doi.org/10.1177/2472555219883623 |
work_keys_str_mv | AT wigletimj forcedselfmodificationassaysasastrategytoscreenmonoparpenzymes AT churchwdavid forcedselfmodificationassaysasastrategytoscreenmonoparpenzymes AT majerchristinar forcedselfmodificationassaysasastrategytoscreenmonoparpenzymes AT swingerkerrenk forcedselfmodificationassaysasastrategytoscreenmonoparpenzymes AT aybardemet forcedselfmodificationassaysasastrategytoscreenmonoparpenzymes AT schenkellaurieb forcedselfmodificationassaysasastrategytoscreenmonoparpenzymes AT vasbindermelissam forcedselfmodificationassaysasastrategytoscreenmonoparpenzymes AT brendesarne forcedselfmodificationassaysasastrategytoscreenmonoparpenzymes AT beckclaudia forcedselfmodificationassaysasastrategytoscreenmonoparpenzymes AT prahmmartin forcedselfmodificationassaysasastrategytoscreenmonoparpenzymes AT wegenerdennis forcedselfmodificationassaysasastrategytoscreenmonoparpenzymes AT changpaul forcedselfmodificationassaysasastrategytoscreenmonoparpenzymes AT kuntzkevinw forcedselfmodificationassaysasastrategytoscreenmonoparpenzymes |